We are drug discovery professionals.
We are industry specialists.
We are scientists.
Crafts(wo)men
We have a responsibility to tackle this challenge.
All
Founders
Leadership
Team
-
Mike Acker
Biophysics & Biochemistry
-
Arman Aksoy
Computational Biology
-
Yonghong Bai
Structural Biology
-
Theresa Baker
Biology
-
Chelsea Bodenstab
Human Resources
-
Erin Brophy
Biophysics & Biochemistry
-
Tom Carter
Administration
-
Kiley Couto
Biology
-
Hannah D’Amato
Human Resources
-
Julia Dooley
Biochemistry & Biophysics
-
Allison Drew
Biology
-
Erica Evans
Biology
-
Kristina Fetalvero
Biology
-
Wenhua Gao
Biology
-
Andy Garner
Biology
-
Daniela Georgieva
Biology
-
Tim Guzi
SVP, Drug Discovery
-
Peter Hammerman
CSO
-
Kate Hardy
Informatics
-
Maureen Hill
Biophysics & Biochemistry
-
Valerie Joseph
Operations
-
Dorothee Kern
HHMI, Brandeis University
-
Walt Kowtoniuk
COO
-
Elden Lainez
Lab & Facilities Operations
-
Sarah Larson
Interim Head of HR
-
Chris Mahoney
Biology
-
Meredeth McGowan
Medicinal Chemistry
-
Doug McLaughlin
Protein Sciences
-
Mike Miller
Finance
-
Daniel Myung
Data Sciences
-
Eva Nogales
HHMI, UC Berkeley
-
Suzann OBrien
Administration
-
Corey O’Keeffe
Communications
-
Asit Parikh
CEO
-
Jenna Perrson
Biology
-
Matt Plant
Biophysics & Biochemistry
-
Christopher Quinn
Biophysics & Biochemistry
-
Gabriela Rodriguez Vasquez
Lab Operations
-
Sneha Sanghavi-Tellis
Biology
-
Laurie Schenkel
Medicinal Chemistry
-
Emma Seabrook
Recruiting
-
Brian Sosa-Alvarado
Structural Biology
-
Anthony Tubbs
Biology
-
Timur Yusufzai
Protein Sciences
-
James Villa
Operations
-
Brian Villalba
Biophysics & Biochemistry
-
Johannes Walter
HHMI, Harvard Medical School
BOARD OF DIRECTORS
Asit Parikh, M.D., Ph.D. — CEO, MOMA Therapeutics
Reid Huber, Ph.D. — Partner, Third Rock Ventures
Christoph Lengauer, Ph.D. — Partner, Third Rock Ventures
Thilo Schroeder, Ph.D — Partner, Nextech Invest
BOARD OBSERVERS
Bihua Chen — CEO, Cormorant Asset Management
Walt Kowtoniuk, Ph.D. — Venture Partner, Third Rock Ventures
Investors
